Sensititre™ Gram Negative Susceptibility Testing Plate, IVD format

Expand your Gram-negative organism susceptibility testing options by accessing the latest antibiotics including cefiderocol and imipenem/relebactam. The Thermo Scientific™ Sensititre™ MDRGN2F plate delivers results directly from broth microdilution (BMD), the gold standard¹ phenotypic method for Antimicrobial Susceptibility Testing (AST). Open access to one of the most comprehensive range of second-line antimicrobials, on a single plate format, designed for in-vitro diagnostic use.

• Updated standard format including Cefiderocol and Imipenem/Relebactam
• IVD-labelled
• BMD provides accurate MIC results guiding treatment optimization
• Meets the latest CLSI breakpoints
• Sensititre MIC determination is achieved using direct measurement rather than relying on extrapolated data, thereby providing an accurate MIC result, not an estimate.
• All contained antibiotics also available in customizable plate options, along with access to over 300 antimicrobials, to enable meeting local formulary and Stewardship program requirements

Thermo Fisher Scientific is a leader in providing AST solutions that help in the fight against antimicrobial resistance, offering high performance automated and manual test options and one of the largest, most up-to-date selections of antimicrobials for susceptibility testing.

The Sensititre System utilizes gold standard-level MIC accuracy¹, providing superior quality and reproducibility for accurate results the first time. Broth microdilution is the reference method for AST, and in many cases ² the most reliable phenotypic method to guide therapeutic decisions.